Hong Kong Daily Briefing

SCMP Business reported that energy security fears globally are driving a surge in orders for Chinese energy storage firms. For HK-listed investors, CATL's Hong Kong secondary listing and BYD's primary HK listing are the direct expressions of this structural order book growth. Global order visibility through 2028 is the thesis anchor — HKEX-listed energy storage names are the preferred vehicle for global investors who want China's manufacturing edge without A-share trading restrictions.

Cross-border biotech deals involving Chinese entities are becoming more complex under US investment scrutiny, per SCMP Business. For HKEX-listed biotech names — Zymeworks (dual-listed), Innovent Biologics, BioNTech HK ventures — US partnership revenue at risk needs to be stress-tested. The Biosecure Act implementation is creating a structural headwind for any HK-listed biotech with material US commercial or partnership revenue.

The US-Iran peace deal is driving crude oil lower, reducing the geopolitical risk premium in Gulf region markets. For the USD/HKD peg, lower oil prices generally mean softer EM capital flows from petrodollar recycling — a marginal headwind for HKMA's convertibility undertaking at the weak side. Business Times SG reported oil glut bets are building post-deal. HKMA peg defense remains solid, but reduced Gulf recycling of energy revenues is worth tracking in the HK interbank market.